Outpatient follow-up of patients with esophageal diseases by a primary care practitioner: esophagitis, gastroesophageal reflux disease, Barrett’s esophagus, achalasia cardia. Guidelines

The guidelines describe the management of outpatient follow-up by a general practitioner of patients with esophageal diseases (esophagitis, gastroesophageal reflux disease, Barrett’s esophagus and achalasia cardia). The following is presented: an approximate scope and frequency of paraclinical investigations, information on the diagnosis, treatment and prevention of complications of diseases. The guidelines are intended for general practitioners, family doctors, as well as for mid-level health providers working with the above-mentioned doctors, for paramedics performing the doctor functions. The guidelines can be used by public health physicians, heads of primary health care facilities and their divisions.

1. Mayev IV, Busarova GA, Andreev DN. Diseases of the esophagus. M.: GEOTARMedia, 2019. p. 648. (In Russ.)

2. Ivashkin VT, Yushchuk ND, Mayev IV, et al. Clinical recommendations of the Russian Gastroenterological Association for the diagnosis and treatment of infectious esophagitis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(5):63-83. (In Russ.)

3. Ivashkin VT, Maev IV, Trukhmanov AS, et al. Clinical recommendations of the Russian Gastroenterological Association for the diagnosis and treatment of eosinophilic esophagitis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(6):84-98. (In Russ.)

4. Ivashkin VT, Maev IV, Trukhmanov AS, et al. Recommendations of the Russian Gastroenterological Association for the diagnosis and treatment of gastroesophageal reflux disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(4):70-97. (In Russ.)

5. Ivashkin VT, Trukhmanov AS, Gojello EA, et al. Recommendations of the Russian Gastroenterological Association for the diagnosis and treatment of achalasia of cardiology and cardiospasm. Russian Journal of Gastroenterology, Hepatology and Coloproctology 2016;26(4):36-54. (In Russ.)

6. Ivashkin VT, Lapina TL, Maev IV, et al. Clinical recommendations of the Russian Gastroenterological Association, the Scientific Community to promote the clinical study of the Human Microbiome, the Russian Society for the Prevention of Noncommunicable Diseases, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy for the diagnosis and treatment of H. pylori in adults. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2022;32(6):72-93. (In Russ.)

7. Namiot Z, Sarosiek J, Marcinkiewicz M, et al. Declined human esophageal mucin secretion in patients with severe reflux esophagitis. Dig. Dis. Sci. 1994;39:2523-9. doi:10.1007/ BF02087685.

8. Niv Y, Fass R. The role of mucin in GERD and its complications. Gastroenterol. Hepatol. 2011;9(1):55-9. doi:10.1038/nrgastro.2011.211.

9. Van Roon AH, Mayne GC, Wijnhoven BPL, et al. Impact of gastro-esophageal reflux on mucin mRNA expression in the esophageal mucosa. J. Gastrointest. Surg. 2008;12:1331-40. doi:10.1007/s11605-008-0522-y.

10. Ivashkin VT, Trukhmanov AS, Gonik MI. The use of rebamipid in the treatment of gastroesophageal reflux disease. Therapeutic Archive. 2020;92(4):98-104. (In Russ.) doi:10.26442/00403660.2020.04.000568.

11. Mayev IV, Dicheva DT, Penkina TV, et al. Diverticula of the upper gastrointestinal tract. Gastroenterology. Appendix to the journal Consilium medicum. 2009;1:8-12. (In Russ.)